Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Loupy

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Journal of the American Society of Nephrology : JASN|August 6, 2016
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft LossDenis Viglietti, Alexandre Loupy, Dewi Vernerey, et al.
Journal of the American Society of Nephrology : JASN|December 20, 2017
Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated RejectionDenis Viglietti, Alexandre Loupy, Olivier Aubert, et al.
Frontiers in Pharmacology|May 14, 2023
Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)François R Girardin, Anna Nicolet, Oriol Bestard, et al.
Transplantation|February 8, 2013
Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantationCécile Courivaud, Jamal Bamoulid, Alexandre Loupy, et al.
JAMA Internal Medicine|August 27, 2019
Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US AcceptanceOlivier Aubert, Peter P Reese, Benoit Audry, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 13, 2019
Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejectionYassine Bouatou, Denis Viglietti, Daniele Pievani, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 6, 2008
High-dosage intravenous immunoglobulin-associated macrovacuoles are associated with chronic tubulointerstitial lesion worsening in renal transplant recipientsGuillaume Bollée, Dany Anglicheau, Alexandre Loupy, et al.
BMJ Open|October 8, 2021
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept studyOlivier Aubert, Gillian Divard, Julio Pascual, et al.
The Journal of Investigative Dermatology|May 7, 2010
Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism at position -765 on skin cancer after renal transplantationFrançois Aubin, Cécile Courivaud, Jamal Bamoulid, et al.
Journal of the American Society of Nephrology : JASN|November 5, 2011
A clinicopathologic study of thrombotic microangiopathy in IgA nephropathyKhalil El Karoui, Gary S Hill, Alexandre Karras, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Journal of the American Society of Nephrology : JASN|August 6, 2016
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft LossDenis Viglietti, Alexandre Loupy, Dewi Vernerey, et al.
Journal of the American Society of Nephrology : JASN|December 20, 2017
Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated RejectionDenis Viglietti, Alexandre Loupy, Olivier Aubert, et al.
Frontiers in Pharmacology|May 14, 2023
Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)François R Girardin, Anna Nicolet, Oriol Bestard, et al.
Transplantation|February 8, 2013
Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantationCécile Courivaud, Jamal Bamoulid, Alexandre Loupy, et al.
JAMA Internal Medicine|August 27, 2019
Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US AcceptanceOlivier Aubert, Peter P Reese, Benoit Audry, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 13, 2019
Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejectionYassine Bouatou, Denis Viglietti, Daniele Pievani, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 6, 2008
High-dosage intravenous immunoglobulin-associated macrovacuoles are associated with chronic tubulointerstitial lesion worsening in renal transplant recipientsGuillaume Bollée, Dany Anglicheau, Alexandre Loupy, et al.
BMJ Open|October 8, 2021
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept studyOlivier Aubert, Gillian Divard, Julio Pascual, et al.
The Journal of Investigative Dermatology|May 7, 2010
Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism at position -765 on skin cancer after renal transplantationFrançois Aubin, Cécile Courivaud, Jamal Bamoulid, et al.
Journal of the American Society of Nephrology : JASN|November 5, 2011
A clinicopathologic study of thrombotic microangiopathy in IgA nephropathyKhalil El Karoui, Gary S Hill, Alexandre Karras, et al.
Pageof 21